Litcius/Paper detail

BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells

Zhongyang Jiang, Ximei Ma, Xiaohui Luan, Zhen‐Yu Liuyang, Yiyang Hong, Yuan Dai, Qinghua Dong, Guanyu Wang

2023World Journal of Gastroenterology10 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Activated hepatic stellate cells (aHSCs) are the major source of cancer-associated fibroblasts in the liver. Although the crosstalk between aHSCs and colorectal cancer (CRC) cells supports liver metastasis (LM), the mechanisms are largely unknown. AIM: To explore the role of BMI-1, a polycomb group protein family member, which is highly expressed in LM, and the interaction between aHSCs and CRC cells in promoting CRC liver metastasis (CRLM). METHODS: . RESULTS: . CONCLUSION: High expression of BMI-1 in liver cells is associated with CRLM progression. BMI-1 activates HSCs to secrete factors to form a prometastatic environment in the liver, and aHSCs promote proliferation, migration, and the EMT in CRC cells partially through the TGF-β/SMAD pathway.

Topics & Concepts

Epithelial–mesenchymal transitionHepatic stellate cellMetastasisColorectal cancerCancer researchSMADPathologyImmunohistochemistryBiologyTransforming growth factorInternal medicineCancerMedicineLiver physiology and pathologyEpigenetics and DNA MethylationCholangiocarcinoma and Gallbladder Cancer Studies